Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion


As Novo Nordisk and Eli Lilly duke it out in the weight-loss drug market with Ozempic, Wegovy and Mounjaro, drug company competitors plan to join the fray…

Share post:



More like this

Uber, Khosla, Nvidia invest in $200 million funding round for autonomous trucking startup Waabi

Autonomous trucking startup Waabi has raised $200 million in...

EU to challenge U.S. and China strategically on trade, competition chief says

The European Union's competition chief Margrethe Vestager said the...

Boeing CEO heads to Senate hearing over safety and manufacturing crises

Boeing is under fire after a door plug blew...